Eli Lilly's potential Houston expansion could bring thousands of jobs and billions of dollars in investment to the area. Here's where the plant might be built ...

Eli Lilly’s total deal value with Rznomics could exceed $1.3 billion, plus royalties. Rznomics will lead early-stage research; Lilly to handle development and sales. Get stock picks, daily ...

Matthew Herper covers medical innovation — both its promise and its perils. A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap ...

[ { "name": "GPT - Billboard - Slot Inline - Content - Labeled - No Desktop", "component": "21721571", "insertPoint": "2", "requiredCountToDisplay": "2" },{ "name ...

Dallas Stars right wing Mikko Rantanen (96) beats Winnipeg Jets goaltender Connor Hellebuyck (37) for a goal during the third period in Game 3 of a second-round NHL hockey playoff series on Sunday ...

DALLAS — A motorcyclist and a young child were killed Saturday evening after a crash in Dallas, according to the Dallas Police Department. Officers responded to a call around 6 p.m. in the 3200 ...

500 winning percentage in 2022, Missouri Tigers head coach Eli Drinkwitz has reinstated confidence in both himself and in the program in the last two seasons. That's led to much more national ...

May 12 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Sunday its drug Zepbound was superior to Novo Nordisk's (NOVOb.CO), opens new tab Wegovy across five weight-loss targets such as ...

The "Tucker and Dale vs. Evil" director tells IndieWire about his new film, the socially-conscious slasher "Clown in a Cornfield." Adapted from Adam Cesare’s novel of the same name, the film ...

Monday marks a major leadership shift in the City of Dallas as two departments officially welcome new leaders. After months of nationwide searches, the city swore in Dallas Fire-Rescue chief ...

U.K.-based biotech Alchemab on Tuesday announced a licensing agreement with Eli Lilly (NYSE:LLY) to jointly develop ATLX-1282, an early-stage therapeutic candidate targeting amyotrophic lateral ...